找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Animal Lectins: Form, Function and Clinical Applications; G. S. Gupta Book 2012 Springer-Verlag Wien 2012 animal lectins.lectins.Protein-L

[復(fù)制鏈接]
樓主: 指責(zé)
41#
發(fā)表于 2025-3-28 16:12:24 | 只看該作者
978-3-7091-4837-2Springer-Verlag Wien 2012
42#
發(fā)表于 2025-3-28 22:06:06 | 只看該作者
43#
發(fā)表于 2025-3-28 23:11:53 | 只看該作者
P-Type Lectins: Cation-Independent Mannose-6-Phosphate Reeptorss IGF-1 and -2, lacks kinase activity and is denoted as type II IGF receptor (IGF2R). The cell surface receptor for IGF2 also functions as a cation-independent M6PR. Therefore, cation-independent mannose 6-phosphate receptor (CI-MPR) is also referred as insulin-like growth factor 2 receptor (IGF2R)
44#
發(fā)表于 2025-3-29 05:14:31 | 只看該作者
Mannose-6-Phosphate Receptor Homologous Protein Familyotranslocation from the ER into the cytosol, and proteasomal degradation through ubiquitination. The quality-control system also surveys the ER lumen for terminally misfolded proteins. Polypeptides singled out by this system are ultimately degraded by the cytosolic ubiquitin-proteasome pathway. Key
45#
發(fā)表于 2025-3-29 10:32:52 | 只看該作者
Lectins of ERAD Pathway: F-Box Proteins and M-Type Lectinsigase and peptide:N-glycanase (PNGase) in the cytosolic ERAD pathway. Mannose trimming plays an important role by forming specific .glycans that permit the recognition and sorting of terminally misfolded conformers for ERAD. The EDEM (ER degradation enhancing α-mannosidase-like protein) subgroup of
46#
發(fā)表于 2025-3-29 14:56:01 | 只看該作者
47#
發(fā)表于 2025-3-29 17:46:56 | 只看該作者
Pentraxins: The L-Type Lectins and the C-Reactive Protein as a Cardiovascular Riskthe primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP), the first innate immunity receptor and serum amyloid P-component (SAP) are the two short pentraxins. Soluble pentraxins act as pattern recognition recepto
48#
發(fā)表于 2025-3-29 22:56:46 | 只看該作者
49#
發(fā)表于 2025-3-30 03:06:22 | 只看該作者
Galectin-1: Forms and Functionscentral nervous system after injury. The targeted overexpression of Gal-1 should be considered as a method of choice for the treatment of some kinds of inflammation-related diseases, neurodegenerative pathologies and muscular dystrophies. In contrast, the targeted inhibition of Gal-1 expression is w
50#
發(fā)表于 2025-3-30 08:00:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 16:41
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
卢龙县| 合作市| 常德市| 黎平县| 曲周县| 安宁市| 治多县| 南投市| 合山市| 嘉定区| 钦州市| 柳林县| 吴堡县| 崇义县| 英吉沙县| 泸水县| 宁德市| 灵石县| 普洱| 周口市| 滨州市| 炉霍县| 通渭县| 台安县| 永顺县| 怀柔区| 荥阳市| 梁河县| 紫阳县| 华池县| 任丘市| 鹿邑县| 上虞市| 贺州市| 改则县| 吴旗县| 广昌县| 民县| 招远市| 汕尾市| 金塔县|